BioNote, Inc. (KRX:377740)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,330.00
-130.00 (-2.38%)
At close: Mar 9, 2026

BioNote Revenue

BioNote had revenue of 29.50B KRW in the quarter ending September 30, 2025, with 11.53% growth. This brings the company's revenue in the last twelve months to 115.09B, up 15.32% year-over-year. In the year 2024, BioNote had annual revenue of 102.78B with 14.10% growth.

Revenue (ttm)
115.09B
Revenue Growth
+15.32%
P/S Ratio
4.69
Revenue / Employee
386.22M
Employees
298
Market Cap
540.26B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024102.78B12.70B14.10%
Dec 31, 202390.08B-389.58B-81.22%
Dec 31, 2022479.66B-142.70B-22.93%
Dec 31, 2021622.36B-9.15B-1.45%
Dec 31, 2020631.50B591.46B1,476.89%
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
T&L Co., Ltd. 177.27B
Value Added Technology 413.76B
Vieworks 230.52B
Dongbang Medical 111.86B
Shinhung 98.94B
CLASSYS 336.80B
EOFLOW 3.98B
PCL, Inc. 4.98B
Revenue Rankings